CERRITO, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 8.724
AS - Asia 4.536
EU - Europa 4.507
SA - Sud America 643
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 9
Totale 18.534
Nazione #
US - Stati Uniti d'America 8.342
SG - Singapore 1.607
IT - Italia 1.223
CN - Cina 1.193
DE - Germania 950
BR - Brasile 496
HK - Hong Kong 486
RU - Federazione Russa 485
VN - Vietnam 456
SE - Svezia 367
CA - Canada 322
IE - Irlanda 302
GB - Regno Unito 282
UA - Ucraina 191
FR - Francia 187
IN - India 172
FI - Finlandia 105
ID - Indonesia 97
AT - Austria 89
KR - Corea 82
DK - Danimarca 78
TR - Turchia 75
BD - Bangladesh 63
AR - Argentina 56
NL - Olanda 53
IQ - Iraq 51
JP - Giappone 51
MX - Messico 39
ZA - Sudafrica 39
PL - Polonia 37
BE - Belgio 32
PK - Pakistan 31
SA - Arabia Saudita 29
ES - Italia 24
VE - Venezuela 21
CO - Colombia 20
PH - Filippine 20
UZ - Uzbekistan 20
CH - Svizzera 18
EC - Ecuador 18
LT - Lituania 18
CL - Cile 13
CZ - Repubblica Ceca 13
MA - Marocco 13
KE - Kenya 12
IR - Iran 11
MY - Malesia 10
EU - Europa 9
JO - Giordania 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
LB - Libano 8
PY - Paraguay 8
AL - Albania 7
HU - Ungheria 7
NP - Nepal 7
PS - Palestinian Territory 7
RS - Serbia 7
EG - Egitto 6
ET - Etiopia 6
KZ - Kazakistan 6
TH - Thailandia 6
TN - Tunisia 6
BO - Bolivia 5
GR - Grecia 5
IL - Israele 5
PE - Perù 5
PT - Portogallo 5
RO - Romania 5
AZ - Azerbaigian 4
BB - Barbados 4
BG - Bulgaria 4
BY - Bielorussia 4
MU - Mauritius 4
NO - Norvegia 4
TW - Taiwan 4
JM - Giamaica 3
OM - Oman 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
PA - Panama 2
PR - Porto Rico 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
CG - Congo 1
CY - Cipro 1
Totale 18.518
Città #
Ann Arbor 1.818
Singapore 1.003
Ashburn 860
Frankfurt am Main 632
San Jose 632
Milan 511
Hong Kong 461
Chandler 355
Wilmington 354
Fairfield 348
Woodbridge 294
Dublin 293
Houston 272
Beijing 260
New York 224
Dearborn 186
Los Angeles 185
Toronto 182
Jacksonville 181
Dallas 138
Ho Chi Minh City 137
Seattle 134
Santa Clara 132
Cambridge 120
Hefei 120
Chicago 109
Hangzhou 109
Hanoi 102
Council Bluffs 100
The Dalles 93
Princeton 88
Shanghai 80
Jakarta 77
Seoul 73
Vienna 73
Munich 68
Buffalo 58
Nanjing 58
São Paulo 55
Lauterbourg 53
Helsinki 46
Moscow 45
Kent 42
Altamura 41
Rome 40
Boardman 39
Lawrence 38
Tokyo 38
Orem 36
Guangzhou 35
London 35
Ottawa 34
Warsaw 32
Lachine 30
Montreal 29
Brooklyn 27
Brussels 27
San Diego 27
Mumbai 26
Denver 25
Fremont 25
Nanchang 25
Lissone 23
Shenyang 23
Phoenix 21
Chennai 20
Desio 20
Atlanta 19
Stockholm 19
Tashkent 19
Amsterdam 18
Haiphong 18
Porto Alegre 18
Dhaka 17
Dong Ket 17
Johannesburg 17
Nuremberg 17
Paris 17
Rio de Janeiro 17
Turku 17
Baghdad 16
Mexico City 16
Poplar 16
Zhengzhou 16
Jinan 15
Manchester 15
Monza 15
Pune 15
Ankara 14
Changsha 14
Da Nang 14
Turin 14
Andover 13
Edmonton 13
Kunming 13
Nürnberg 13
San Francisco 13
Buenos Aires 12
Hebei 12
Tianjin 12
Totale 12.388
Nome #
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation 644
Magnetic tweezers measurements of the nanomechanical stability of DNA against denaturation at various conditions of pH and ionic strength 582
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers 581
Combinations of a btk inhibitor and fluorouracil for treating cancers 572
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype 557
Pharmaceutical kit for use in the treatment of colon and colorectal cancer 532
GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis 518
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma 480
Platinum-Based Drugs and DNA Interactions Studied by Single-Molecule and Bulk Measurements 472
Biliverdin Protects against Liver Ischemia Reperfusion Injury in Swine 451
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. 449
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 441
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 424
Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-α-induced injury in vitro 404
Does additional coronary artery bypass grafting to aortic valve replacement in elderly patients affect the early and long-term outcome? 393
CMV-based episomal vector is progressively lost in vivo in multi-gene transgenic pigs produced by SMGT 388
Pathogenetic role of hypercholesterolemia in a novel preclinical model of vascular injury in pigs 377
Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients 372
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer 363
Diet Induced Mild Hypercholesterolemia in Pigs: Local and Systemic Inflammation, Effects on Vascular Injury - Rescue by High-Dose Statin Treatment 351
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 349
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 345
Genetically modified pigs produced with a nonviral episomal vector 335
Evaluation of systemic and tissue-specific inflammation as risk factor for atherosclerosis in pigs fed with high-fat diet 335
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 332
In vitro production of multigene transgenic blastocysts via sperm-mediated gene transfer allows rapid screening of constructs to be used in xenotransplantation experiments 331
Sperm-mediated gene transfer 330
Heme oxygenase-1 inhibition prevents intimal hyperplasia enhancing nitric oxide-dependent apoptosis of vascular smooth muscle cells 311
Minimal Extracorporeal Circulation and Minimally Invasive Valve Operations: Should They Be the Right Combination in the Future? 310
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer 307
Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination 303
Mild-hypercholesterolemia exacerbates intimal hyperplasia after vascular injury by suppressing heme oxygenase-1 expression 295
Sperm-Mediated Genetic Modifications 294
The antiangiogenic effect of the metronomic combination of 5-Fluorouracil plus vinorelbine is mediated by FAK/AKT pathway downregulation and apoptosis activation 290
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells 287
Simultaneous over-expression of graft protective hHO-1, hCD73 and hCD39: effects against cell cytotoxicity and cell death induced by the inflammatory cytokine TNF-α in an in vitro model 284
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors 281
Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5′-nucleotidase in pig endothelial cells 270
Heme oxygenase-1 and nitric oxide in the vasculature: in vivo balloon injury and in vitro VSMC studies in rats 267
Production of multi-gene transgenic pigs by sperm-mediated gene transfer for xenotransplantation 265
Infusion of escherichia coli lipopolysaccharide toxin in rats produces an early and severe impairment of baroreflex function in absence of blood pressure changes 263
Statins Reduce Vascular Injury in a Preclinical and Clinical Model of Arteriosclerosis 254
Simultaneous expression of novel combinations of graft protective human genes in porcine endothelial cells 253
Emerging actionable targets to treat therapy-resistant colorectal cancers 248
Identifying novel actionable targets in colon cancer 247
Molecular therapy as a new strategy in the prevention of restenosis. Role of NO/iNOS and CO/HO-1 in inhibition of intimal hyperplasia in a rodent model of balloon injury 240
Role of nitric oxide and heme oxygenase-1 in the prevention of intimal hyperplasia development 239
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 237
Methods for sperm-mediated gene transfer 230
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study 209
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story 206
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity 199
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows 198
"Ironing out" fasting-induced persister cancer cells to render chemotherapy effective: is this the solution? 171
Metronomic chemotherapy 169
BTK, the new kid on the (oncology) block? 165
Targeting p65BTK for treating solid cancers 137
Metronomic 5-Fluorouracil and Vinorelbine Reduce Cancer Stemness and Modulate EZH2/NOTCH-1/STAT3 Signaling in Triple-Negative Breast Cancer Spheroids 20
Totale 19.157
Categoria #
all - tutte 56.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021281 0 0 0 0 0 0 0 0 0 0 118 163
2021/2022928 122 131 140 76 35 45 52 25 33 46 91 132
2022/20231.757 165 469 158 189 127 228 68 85 92 64 58 54
2023/20241.268 77 66 69 121 112 278 232 63 48 29 33 140
2024/20252.704 145 258 212 136 208 137 177 100 263 433 238 397
2025/20266.814 823 398 536 805 979 351 1.206 268 536 623 289 0
Totale 19.157